- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cipla Global Supply Chain Head Venkata Sai Mungara Moves to Cipla USA Role

Mumbai: Cipla Limited has announced that Venkata Sai Mungara, currently Global Head Supply Chain, will transition to the role of Chief of Manufacturing and Supply Chain Operations of Cipla USA Inc., a wholly owned subsidiary of the company, with effect from October 1, 2026. Following the transition, Mungara will cease to be a Senior Management Personnel of Cipla Limited.
Venkata Sai Mungara will move from his existing position as Global Head Supply Chain to Chief of Manufacturing and Supply Chain Operations of Cipla USA Inc. The transition to the wholly owned subsidiary will take effect from October 1, 2026. Consequently, he will cease to hold the position of Senior Management Personnel of Cipla Limited from the same date.
The company has specified that the change is pursuant to Mungara’s transition to the new role at Cipla USA Inc. The terms of appointment or reappointment are stated as not applicable. The brief profile section is also marked as not applicable, as is the disclosure concerning relationships between directors in the case of appointment of a director.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

